Guidance
3 Committee considerations
The evidence
3.1 NICE did a rapid review of the published literature on the efficacy and safety of this procedure. This comprised a comprehensive literature search and detailed review of the evidence from 5 sources, which was discussed by the committee. The evidence included 4 systematic reviews and meta-analysis and 1 case report. It is presented in table 2 of the interventional procedures overview. Other relevant literature is in the appendix of the overview.
3.2 The specialist advisers and the committee considered the key efficacy outcomes in the baby to be: motor function, hind brain herniation, hydrocephalus, bowel and bladder function and need for further surgery.
3.3 The specialist advisers and the committee considered the key safety outcomes in the baby to be: fetal mortality, perinatal death, premature birth, premature rupture of membranes, cerebrospinal fluid leakage and the potential for late spinal cord complications including tethered spinal cord and syringomyelia. Key safety outcomes for the mother are: operative mortality, morbidity, incisional hernia, amniotic fluid leakage, uterine dehiscence or rupture in the current or subsequent pregnancy and morbidly adherent placenta in subsequent pregnancies.
3.4 Patient commentary was sought but none was received.
Committee comments
3.5 The committee was advised that fetoscopic approaches may have reduced risks for the mother, in particular the risk of uterine rupture in a subsequent pregnancy.
3.6 The committee was advised that there is a registry based in the US for this procedure.
3.7 The committee noted the need to identify the risks and benefits for both the fetus and mother (including her subsequent pregnancies) including long-term outcomes, and that these need to be discussed during parental counselling by the multidisciplinary team.